80067794 - 21st Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseases

Friday, September 12, 2025, 7:00 AM - Saturday, September 13, 2025, 5:00 PM, Johns Hopkins Tilghman Room, Baltimore, MD


Now in its 21st year, this two-day symposium has been planned for the providers who care for patients with rheumatic disease. Given the wide variety of rheumatologic disorders, and an ever increasing number of diagnostic procedures and treatment options, it is necessary to provide clinicians with information about strategies for the early diagnosis of these conditions, novel state-of-the-art diagnostic tools, and opportunities to utilize the most effective treatments to ensure optimal patient outcomes.

1. Identify new treatment strategies in lupus nephritis.
2. Describe screening metrics for steroid induced osteoporosis and outline potential treatment paradigms.
3. Recognize the different subtypes of juvenile idiopathic arthritis (JIA).
4. Characterize new drugs for pulmonary hypertension in autoimmune disease.
5. Distinguish new and novel treatments for psoriatic arthritis.

Canopy by Hilton Baltimore Harbor Point
1215 Wills Street
Baltimore, MD 21231
Phone: 443-960- 8681
Fax: 443-960-8671
Hotel Rate: $219.00
Hotel Link: https://www.hilton.com/en/book/reservation/deeplink/?ctyhocn=BWIHPPY&groupCode=AAD&arrivaldate=2025-09-11&departuredate=2025-09-13&cid=OM,WW,HILTONLINK,EN,DirectLink&fromId=HILTONLINKDIRECT
Hotel Registration Cut Off Date: 8/12/2025

Residence Inn Baltimore at The Johns Hopkins Medical Campus
800 N Wolfe Street
Baltimore, MD 21205
Phone: (844) 490-1771
Hotel Rate: $155.00
Hotel Link: https://www.marriott.com/event-reservations/reservation-link.mi?id=1742222274186&key=GRP&guestreslink2=true&app=resvlink
Hotel Registration Cut Off Date: 8/21/2025

Mitigation of Relevant Financial Relationships

Johns Hopkins University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.